BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8340384)

  • 1. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell.
    Sugino K; Kurosawa N; Nakamura T; Takio K; Shimasaki S; Ling N; Titani K; Sugino H
    J Biol Chem; 1993 Jul; 268(21):15579-87. PubMed ID: 8340384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follistatin and its role as an activin-binding protein.
    Sugino H; Sugino K; Hashimoto O; Shoji H; Nakamura T
    J Med Invest; 1997 Aug; 44(1-2):1-14. PubMed ID: 9395712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells.
    Nakamura T; Sugino K; Titani K; Sugino H
    J Biol Chem; 1991 Oct; 266(29):19432-7. PubMed ID: 1918055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate.
    Hashimoto O; Nakamura T; Shoji H; Shimasaki S; Hayashi Y; Sugino H
    J Biol Chem; 1997 May; 272(21):13835-42. PubMed ID: 9153241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant expression of human follistatin with 315 and 288 amino acids: chemical and biological comparison with native porcine follistatin.
    Inouye S; Guo Y; DePaolo L; Shimonaka M; Ling N; Shimasaki S
    Endocrinology; 1991 Aug; 129(2):815-22. PubMed ID: 1906804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors.
    de Winter JP; ten Dijke P; de Vries CJ; van Achterberg TA; Sugino H; de Waele P; Huylebroeck D; Verschueren K; van den Eijnden-van Raaij AJ
    Mol Cell Endocrinol; 1996 Jan; 116(1):105-14. PubMed ID: 8822271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of Xenopus embryo heparan sulfate. Differential structural requirements for the specific binding to basic fibroblast growth factor and follistatin.
    Yamane Y; Tohno-oka R; Yamada S; Furuya S; Shiokawa K; Hirabayashi Y; Sugino H; Sugahara K
    J Biol Chem; 1998 Mar; 273(13):7375-81. PubMed ID: 9516434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of activin-binding protein by rat granulosa cells in vitro.
    Saito S; Nakamura T; Titani K; Sugino H
    Biochem Biophys Res Commun; 1991 Apr; 176(1):413-22. PubMed ID: 1902106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of Xenopus follistatin and activins.
    Fukui A; Nakamura T; Sugino K; Takio K; Uchiyama H; Asashima M; Sugino H
    Dev Biol; 1993 Sep; 159(1):131-9. PubMed ID: 8365557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
    Sidis Y; Tortoriello DV; Holmes WE; Pan Y; Keutmann HT; Schneyer AL
    Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically.
    Schneyer AL; Hall HA; Lambert-Messerlian G; Wang QF; Sluss P; Crowley WF
    Endocrinology; 1996 Jan; 137(1):240-7. PubMed ID: 8536619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of native activin B.
    Nakamura T; Asashima M; Eto Y; Takio K; Uchiyama H; Moriya N; Ariizumi T; Yashiro T; Sugino K; Titani K
    J Biol Chem; 1992 Aug; 267(23):16385-9. PubMed ID: 1644823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells.
    Hosseini G; Liu J; de Agostini AI
    J Biol Chem; 1996 Sep; 271(36):22090-9. PubMed ID: 8703018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin-A regulates follistatin secretion from cultured rat anterior pituitary cells.
    Bilezikjian LM; Corrigan AZ; Vaughan JM; Vale WM
    Endocrinology; 1993 Dec; 133(6):2554-60. PubMed ID: 8243277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin.
    Hashimoto O; Kawasaki N; Tsuchida K; Shimasaki S; Hayakawa T; Sugino H
    Cell Signal; 2000 Aug; 12(8):565-71. PubMed ID: 11027950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the activin-binding protein follistatin cultured human luteinizing granulosa cells: characterization of the effects of follicle stimulating hormone, prostaglandin E2, and different growth factors.
    Tuuri T; Ritvos O
    Biol Reprod; 1995 Dec; 53(6):1508-16. PubMed ID: 8562709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follistatin: essential role for the N-terminal domain in activin binding and neutralization.
    Sidis Y; Schneyer AL; Sluss PM; Johnson LN; Keutmann HT
    J Biol Chem; 2001 May; 276(21):17718-26. PubMed ID: 11279126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin-binding protein is present in pituitary.
    Kogawa K; Nakamura T; Sugino K; Takio K; Titani K; Sugino H
    Endocrinology; 1991 Mar; 128(3):1434-40. PubMed ID: 1900230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of human follistatin structure: identification of two discontinuous N-terminal sequences coding for activin A binding and structural consequences of activin binding to native proteins.
    Wang Q; Keutmann HT; Schneyer AL; Sluss PM
    Endocrinology; 2000 Sep; 141(9):3183-93. PubMed ID: 10965889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.